Showing results (41-50 of 126) with videos related to
Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry|March 16, 2013
Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABA(A)) receptorGabriella Guerrini, Giovanna Ciciani, Annarella Costanzo, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2015
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic studyGabriella Guerrini, Giovanna Ciciani, Samuele Ciattini, et al.Biology|May 28, 2022
What Does the Brain Have to Keep Working at Its Best? Resilience Mechanisms Such as Antioxidants and Brain/Cognitive Reserve for Counteracting Alzheimer's Disease DegenerationDavide Maria Cammisuli, Ferdinando Franzoni, Giorgia Scarfò, et al.Frontiers in Pharmacology|February 16, 2018
The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung CellsChiara Giacomelli, Simona Daniele, Chiara Romei, et al.Oxidative Medicine and Cellular Longevity|June 1, 2018
Epigenetic Modifications of the α-Synuclein Gene and Relative Protein Content Are Affected by Ageing and Physical Exercise in Blood from Healthy SubjectsSimona Daniele, Barbara Costa, Deborah Pietrobono, et al.Oxidative Medicine and Cellular Longevity|July 9, 2019
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated MouseRebecca Piccarducci, Deborah Pietrobono, Carolina Pellegrini, et al.Biomolecules|October 26, 2024
Endometrial Dysbiosis: A Possible Association with Estrobolome AlterationGiorgia Scarfò, Simona Daniele, Elisa Chelucci, et al.Oncotarget|January 14, 2016
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cellsSimona Daniele, Elisabetta Barresi, Elisa Zappelli, et al.Journal of Medicinal Chemistry|March 16, 2011
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonistsDaniela Poli, Daniela Catarzi, Vittoria Colotta, et al.ACS Chemical Neuroscience|August 4, 2012
3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effectsAlessia Scatena, Francesco Fornai, Maria Letizia Trincavelli, et al.Pageof 13